The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus
NCT ID: NCT06362005
Last Updated: 2025-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2024-05-01
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group I (triamcinolone)
ten patients with oral lichen planus, will receive topical triamcinolone acetonide 0.1% four times per day for six weeks.
Triamcinolone Acetonide 0.1% Oint
RCT
group II (tacrollimus)
ten patients with oral lichen planus, will receive topical tacrolimus 0.1% four times per day for six weeks.
Tacrollimus Topical
RCT
group III (selenium)
ten patients with oral lichen planus, will receive topical selenium four times per day for six weeks.
Selenium
RCT
group IV (selenium + triamcinolone )
: ten patients with oral lichen planus, will receive topical selenium combined with topical triamcinolone acetonide 0.1% three times per day for each for six weeks
Selenium & Triamcinolone Acetonide 0.1% Oint
RCT
group V ( selenium + tacrollimus)
ten patients with oral lichen planus, will receive topical selenium combined with topical tacrolimus 0.1% three times per day for each for six weeks.
Selenium& Tacrollimus topical
RCT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triamcinolone Acetonide 0.1% Oint
RCT
Tacrollimus Topical
RCT
Selenium
RCT
Selenium & Triamcinolone Acetonide 0.1% Oint
RCT
Selenium& Tacrollimus topical
RCT
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. any systemic autoimmune disease
3. Pregnancy
4. smokers
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sphinx university
OTHER
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaymaa Hussein Rafat Kotb
Assistant lecturere of oral medicine ,periodontology departement
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alazhar university ,faculty of Dental Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUAREC2023011-1
Identifier Type: -
Identifier Source: org_study_id